Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 16;20(Suppl 8):548.
doi: 10.1186/s12864-019-5868-x.

PhenPath: a tool for characterizing biological functions underlying different phenotypes

Affiliations

PhenPath: a tool for characterizing biological functions underlying different phenotypes

Giulia Babbi et al. BMC Genomics. .

Abstract

Background: Many diseases are associated with complex patterns of symptoms and phenotypic manifestations. Parsimonious explanations aim at reconciling the multiplicity of phenotypic traits with the perturbation of one or few biological functions. For this, it is necessary to characterize human phenotypes at the molecular and functional levels, by exploiting gene annotations and known relations among genes, diseases and phenotypes. This characterization makes it possible to implement tools for retrieving functions shared among phenotypes, co-occurring in the same patient and facilitating the formulation of hypotheses about the molecular causes of the disease.

Results: We introduce PhenPath, a new resource consisting of two parts: PhenPathDB and PhenPathTOOL. The former is a database collecting the human genes associated with the phenotypes described in Human Phenotype Ontology (HPO) and OMIM Clinical Synopses. Phenotypes are then associated with biological functions and pathways by means of NET-GE, a network-based method for functional enrichment of sets of genes. The present version considers only phenotypes related to diseases. PhenPathDB collects information for 18 OMIM Clinical synopses and 7137 HPO phenotypes, related to 4292 diseases and 3446 genes. Enrichment of Gene Ontology annotations endows some 87.7, 86.9 and 73.6% of HPO phenotypes with Biological Process, Molecular Function and Cellular Component terms, respectively. Furthermore, 58.8 and 77.8% of HPO phenotypes are also enriched for KEGG and Reactome pathways, respectively. Based on PhenPathDB, PhenPathTOOL analyzes user-defined sets of phenotypes retrieving diseases, genes and functional terms which they share. This information can provide clues for interpreting the co-occurrence of phenotypes in a patient.

Conclusions: The resource allows finding molecular features useful to investigate diseases characterized by multiple phenotypes, and by this, it can help researchers and physicians in identifying molecular mechanisms and biological functions underlying the concomitant manifestation of phenotypes. The resource is freely available at http://phenpath.biocomp.unibo.it .

Keywords: Biological process; Diseases; Enrichment; Molecular pathway; Phenotype.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
OMIM diseases as a function of associated HPO phenotypes. Data include 3837 HPO phenotypes (leaves of the HPO ontology) associated with 4023 OMIM diseases (Table 1, second row). Only 623 diseases (15%) are associated with a single phenotype, while about half of the diseases (47%) are associated with 5 or more phenotypes. Rubinstein-Taybi syndrome has the maximum number of associated HPO phenotypes (48, considering only leaves of the HPO graph)
Fig. 2
Fig. 2
Number of diseases and genes associated with OMIM Clinical Synopsis terms. Blue bars (diseases); red bars (genes)
Fig. 3
Fig. 3
Number of diseases and genes associated with HPO Phenotypic Abnormalities sub-ontology. The 24 roots refer to anatomic districts and physiological functions. Blue bars (diseases); red bars (genes)
Fig. 4
Fig. 4
Selection of phenotypes in PhenPathTOOL. After searching with a list of different names, the web interface shows all the names that do not correspond to any HPO identifier and then a table with all the HPO terms matching the input. The user may then select the most appropriate phenotypes to be analyzed
Fig. 5
Fig. 5
PhenPathTOOL results. The figure shows the webpage of PhenPathTOOL after the analysis of 6 different HPO phenotypes. First, a list of the shared diseases and genes is reported. Then, a general table collects data on diseases and genes associated with each phenotype, allowing direct intersection. The last section reports the links to the analysis of GO terms, KEGG and Reactome pathways

Similar articles

Cited by

References

    1. Fisch GS. Whither the genotype-phenotype relationship? An historical and methodological appraisal. Am J Med Genet C Semin Med Genet. 2017;175:343–353. doi: 10.1002/ajmg.c.31571. - DOI - PubMed
    1. Hu JX, et al. Network biology concepts in complex disease comorbidities. Nat Rev Genet. 2016;17:615–629. doi: 10.1038/nrg.2016.87. - DOI - PubMed
    1. Zielinski A, Halling A. Association between age, gender and multimorbidity level and receiving home health care: a population-based Swedish study. BMC Research Notes. 2015;8:714. doi: 10.1186/s13104-015-1699-2. - DOI - PMC - PubMed
    1. Brodie A, et al. Large-scale analysis of phenotype-pathway relationships based on GWAS results. PLoS One. 2014;9:e100887. doi: 10.1371/journal.pone.0100887. - DOI - PMC - PubMed
    1. Ramos EM, et al. Phenotype-genotype integrator (PheGenI): synthesizing genome-wide association study (GWAS) data with existing genomic resources. Eur J Hum Genet. 2014;22:144–147. doi: 10.1038/ejhg.2013.96. - DOI - PMC - PubMed

LinkOut - more resources